annual CFF:
$49.66M+$74.87M(+297.03%)Summary
- As of today (September 15, 2025), AKBA annual cash flow from financing activities is $49.66 million, with the most recent change of +$74.87 million (+297.03%) on December 31, 2024.
- During the last 3 years, AKBA annual CFF has fallen by -$84.07 million (-62.86%).
- AKBA annual CFF is now -78.57% below its all-time high of $231.72 million, reached on December 31, 2020.
Performance
AKBA Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$1.72M-$73.22M(-97.70%)Summary
- As of today (September 15, 2025), AKBA quarterly cash flow from financing activities is $1.72 million, with the most recent change of -$73.22 million (-97.70%) on June 1, 2025.
- Over the past year, AKBA quarterly CFF has dropped by -$5.92 million (-77.49%).
- AKBA quarterly CFF is now -98.80% below its all-time high of $142.81 million, reached on June 30, 2020.
Performance
AKBA quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$100.21M-$5.92M(-5.58%)Summary
- As of today (September 15, 2025), AKBA TTM cash flow from financing activities is $100.21 million, with the most recent change of -$5.92 million (-5.58%) on June 1, 2025.
- Over the past year, AKBA TTM CFF has increased by +$75.33 million (+302.85%).
- AKBA TTM CFF is now -66.10% below its all-time high of $295.63 million, reached on September 30, 2020.
Performance
AKBA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AKBA Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +297.0% | -77.5% | +302.9% |
| 3 y3 years | -62.9% | +10000.0% | +44.4% |
| 5 y5 years | -44.2% | -98.8% | -66.0% |
AKBA Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -62.9% | +297.0% | -97.7% | +105.2% | -5.6% | +276.1% |
| 5 y | 5-year | -78.6% | +297.0% | -98.8% | +105.2% | -66.1% | +276.1% |
| alltime | all time | -78.6% | +297.0% | -98.8% | +105.2% | -66.1% | +276.1% |
AKBA Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.72M(-97.7%) | $100.21M(-5.6%) |
| Mar 2025 | - | $74.94M(+235.7%) | $106.13M(+113.7%) |
| Dec 2024 | $49.66M(-297.0%) | $22.32M(+1725.4%) | $49.66M(+90.7%) |
| Sep 2024 | - | $1.22M(-84.0%) | $26.05M(+4.7%) |
| Jun 2024 | - | $7.64M(-58.6%) | $24.88M(+169.4%) |
| Mar 2024 | - | $18.48M(-1532.2%) | $9.23M(-136.6%) |
| Dec 2023 | -$25.21M(-272.7%) | -$1.29M(-2680.0%) | -$25.21M(+5.4%) |
| Sep 2023 | - | $50.00K(-100.6%) | -$23.92M(-58.0%) |
| Jun 2023 | - | -$8.00M(-49.9%) | -$56.90M(+16.3%) |
| Mar 2023 | - | -$15.97M(>+9900.0%) | -$48.91M(-435.1%) |
| Dec 2022 | $14.60M(-89.1%) | -$1000.00(-100.0%) | $14.60M(-27.0%) |
| Sep 2022 | - | -$32.94M(>+9900.0%) | $20.00M(-71.2%) |
| Jun 2022 | - | -$9000.00(-100.0%) | $69.42M(-35.0%) |
| Mar 2022 | - | $47.55M(+780.0%) | $106.80M(-20.1%) |
| Dec 2021 | $133.73M(-42.3%) | $5.40M(-67.2%) | $133.73M(-15.8%) |
| Sep 2021 | - | $16.48M(-55.9%) | $158.84M(+10.8%) |
| Jun 2021 | - | $37.37M(-49.8%) | $143.41M(-42.4%) |
| Mar 2021 | - | $74.48M(+144.1%) | $248.85M(+7.4%) |
| Dec 2020 | $231.72M(+160.4%) | $30.51M(+2794.8%) | $231.72M(-21.6%) |
| Sep 2020 | - | $1.05M(-99.3%) | $295.63M(+0.3%) |
| Jun 2020 | - | $142.81M(+149.0%) | $294.77M(+83.4%) |
| Mar 2020 | - | $57.35M(-39.3%) | $160.76M(+80.7%) |
| Dec 2019 | $88.97M(-7.9%) | $94.42M(>+9900.0%) | $88.97M(-1759.0%) |
| Sep 2019 | - | $195.00K(-97.8%) | -$5.36M(+3.1%) |
| Jun 2019 | - | $8.80M(-160.9%) | -$5.20M(-62.3%) |
| Mar 2019 | - | -$14.45M(<-9900.0%) | -$13.80M(-114.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $96.56M(-16.9%) | $85.00K(-76.0%) | $96.56M(-5.1%) |
| Sep 2018 | - | $354.00K(+67.0%) | $101.72M(-38.4%) |
| Jun 2018 | - | $212.00K(-99.8%) | $165.15M(-21.5%) |
| Mar 2018 | - | $95.91M(+1729.3%) | $210.41M(+81.0%) |
| Dec 2017 | $116.24M(+73.6%) | $5.24M(-91.8%) | $116.24M(+1.5%) |
| Sep 2017 | - | $63.78M(+40.3%) | $114.53M(+115.8%) |
| Jun 2017 | - | $45.47M(+2504.0%) | $53.07M(+606.7%) |
| Mar 2017 | - | $1.75M(-50.5%) | $7.51M(-88.8%) |
| Dec 2016 | $66.95M(-19.4%) | $3.53M(+51.5%) | $66.95M(-1.2%) |
| Sep 2016 | - | $2.33M(-2577.7%) | $67.76M(-14.6%) |
| Jun 2016 | - | -$94.00K(-100.2%) | $79.38M(-45.0%) |
| Mar 2016 | - | $61.18M(+1309.7%) | $144.23M(+73.6%) |
| Dec 2015 | $83.09M(-20.4%) | $4.34M(-68.9%) | $83.09M(+5.6%) |
| Sep 2015 | - | $13.95M(-78.5%) | $78.70M(+21.8%) |
| Jun 2015 | - | $64.75M(>+9900.0%) | $64.63M(-5053.3%) |
| Mar 2015 | - | $49.00K(-202.1%) | -$1.30M(-101.2%) |
| Dec 2014 | $104.40M(+146.6%) | -$48.00K(-61.5%) | $104.40M(+0.2%) |
| Sep 2014 | - | -$124.60K(-89.5%) | $104.23M(-0.1%) |
| Jun 2014 | - | -$1.18M(-101.1%) | $104.32M(-28.4%) |
| Mar 2014 | - | $105.75M(<-9900.0%) | $145.60M(+244.0%) |
| Dec 2013 | $42.33M(+1610.5%) | -$215.50K(+428.2%) | $42.33M(-0.5%) |
| Sep 2013 | - | -$40.80K(-100.1%) | $42.55M(-0.1%) |
| Jun 2013 | - | $40.10M(+1515.3%) | $42.59M(+1615.3%) |
| Mar 2013 | - | $2.48M | $2.48M |
| Dec 2012 | $2.47M(-86.0%) | - | - |
| Dec 2011 | $17.72M | - | - |
FAQ
- What is Akebia Therapeutics, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual CFF year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly CFF year-on-year change?
- What is Akebia Therapeutics, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. TTM CFF year-on-year change?
What is Akebia Therapeutics, Inc. annual cash flow from financing activities?
The current annual CFF of AKBA is $49.66M
What is the all time high annual CFF for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual cash flow from financing activities is $231.72M
What is Akebia Therapeutics, Inc. annual CFF year-on-year change?
Over the past year, AKBA annual cash flow from financing activities has changed by +$74.87M (+297.03%)
What is Akebia Therapeutics, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of AKBA is $1.72M
What is the all time high quarterly CFF for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly cash flow from financing activities is $142.81M
What is Akebia Therapeutics, Inc. quarterly CFF year-on-year change?
Over the past year, AKBA quarterly cash flow from financing activities has changed by -$5.92M (-77.49%)
What is Akebia Therapeutics, Inc. TTM cash flow from financing activities?
The current TTM CFF of AKBA is $100.21M
What is the all time high TTM CFF for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high TTM cash flow from financing activities is $295.63M
What is Akebia Therapeutics, Inc. TTM CFF year-on-year change?
Over the past year, AKBA TTM cash flow from financing activities has changed by +$75.33M (+302.85%)